Trial Purpose
The purpose of this clinical research study is to learn if apixaban is more effective than Acetylsalicylic Acid (ASA) in preventing strokes associated with subjects who have atrial fibrillation. The safety of this treatment will also be studied.
Patient Eligibility Requirements
This study is ongoing, but not recruiting participants.
Links
clinicaltrials.gov →
New England Journal of Medicine Article on Averroes →